Home LiteratureArticle Details
PMID: 8146130 Published · ppublish English Journal Article Review

Hepatitis viruses: changing patterns of human disease.

Purcell RH

Abstract

Viral hepatitis is a disease of antiquity, but evidence for more than one etiologic agent has been recognized only since the 1940s, when two viruses (hepatitis A virus and hepatitis B virus) were thought to account for all disease. In the past 20 years, three additional hepatitis agents (hepatitis C virus, hepatitis D virus, and hepatitis E virus) have been discovered, and there is evidence for at least one additional virus. Each of the five recognized hepatitis viruses belongs to a different virus family, and each has a unique epidemiology. The medical impact of these viruses on society has been strongly influenced by changes in human ecology. This has resulted in some cases in diminished disease and in others in increases in the incidence of disease.

MeSH Terms
Behavior Hepacivirus/pathogenicity Hepatitis B virus/pathogenicity Hepatitis Delta Virus/pathogenicity Hepatitis E virus/pathogenicity Hepatitis, Viral, Human/epidemiology,microbiology,pathology Hepatovirus/pathogenicity Humans
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Purcell R H
Hepatitis Viruses Section, National Institute of Allergies and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
References (40)
40 references, click to expand
  1. Immunity in hepatitis C infection.
    J Infect Dis. 1992 Mar;165(3):438-43 PMID: 1538149
  2. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.
    J Virol. 1993 Apr;67(4):1953-8 PMID: 8383220
  3. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
    Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3468-72 PMID: 1314389
  4. Hepatitis B and hepatitis C in emergency department patients.
    N Engl J Med. 1992 May 21;326(21):1399-404 PMID: 1373867
  5. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions.
    J Gen Virol. 1992 Jun;73 ( Pt 6):1365-77 PMID: 1318940
  6. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides.
    J Virol Methods. 1992 Jul;38(1):175-86 PMID: 1644893
  7. p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts.
    Virology. 1992 Nov;191(1):431-4 PMID: 1329328
  8. Lack of protective immunity against reinfection with hepatitis C virus.
    Science. 1992 Oct 2;258(5079):135-40 PMID: 1279801
  9. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.
    N Engl J Med. 1992 Dec 31;327(27):1899-905 PMID: 1280771
  10. The epidemiology of antibody to hepatitis C in Egypt.
    J Infect Dis. 1993 Sep;168(3):789-90 PMID: 8394867
  11. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.
    Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8234-8 PMID: 8396266
  12. A genotype of hepatitis D virus that occurs in northern South America.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9016-20 PMID: 8415646
  13. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children.
    Lancet. 1994 Feb 12;343(8894):388-90 PMID: 7905553
  14. Vaccination of chimpanzees against infection by the hepatitis C virus.
    Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1294-8 PMID: 7509068
  15. Introduction of hepatitis delta virus into Polish drug community.
    Infection. 1992 Jan-Feb;20(1):43-4 PMID: 1563812
  16. Transfusion-associated hepatitis not due to viral hepatitis type A or B.
    N Engl J Med. 1975 Apr 10;292(15):767-70 PMID: 163436
  17. Vertical transmission of hepatitis B antigen in Taiwan.
    N Engl J Med. 1975 Apr 10;292(15):771-4 PMID: 1113797
  18. Propagation of human hepatitis A virus in cell culture in vitro.
    Proc Soc Exp Biol Med. 1979 Feb;160(2):213-21 PMID: 217023
  19. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli.
    Lancet. 1980 Apr 19;1(8173):887 PMID: 6103253
  20. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.
    Am J Med. 1980 Jun;68(6):818-24 PMID: 6770682
  21. Non-A, non-B hepatitis in chimpanzees and marmosets.
    J Infect Dis. 1981 Dec;144(6):588-98 PMID: 6799586
  22. Dialysis-associated hepatitis in Edinburgh; 1969-1978.
    Rev Infect Dis. 1982 May-Jun;4(3):619-37 PMID: 6812192
  23. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features.
    Gastroenterology. 1983 Aug;85(2):439-62 PMID: 6305760
  24. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route.
    Intervirology. 1983;20(1):23-31 PMID: 6409836
  25. Epidemiology of delta infection in Scandinavia.
    Prog Clin Biol Res. 1983;143:155-9 PMID: 6669568
  26. Primate animal models and titered inocula for the study of human hepatitis A, hepatitis B, and non-A, non-B hepatitis.
    J Med Primatol. 1983;12(6):305-18 PMID: 6094814
  27. Delta hepatitis--present status.
    J Hepatol. 1985;1(2):187-93 PMID: 4056344
  28. Titration of the infectivity of hepatitis D virus in chimpanzees.
    J Infect Dis. 1987 Jan;155(1):72-8 PMID: 3794405
  29. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes.
    J Gen Virol. 1988 Oct;69 ( Pt 10):2575-83 PMID: 3171552
  30. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.
    Science. 1989 Apr 21;244(4902):359-62 PMID: 2523562
  31. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.
    JAMA. 1989 Sep 1;262(9):1201-5 PMID: 2503630
  32. [Serological proof of the existence of a variety of non-A, non-B hepatitis with a fecal-oral transmission mechanism].
    Vopr Virusol. 1989 Mar-Apr;34(2):164-7 PMID: 2548344
  33. Cytoplasmic antigen in hepatocytes of chimpanzees infected with non-A, non-B hepatitis virus or hepatitis delta virus: relationship to interferon.
    Hepatology. 1989 Nov;10(5):764-8 PMID: 2478436
  34. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.
    JAMA. 1990 Mar 2;263(9):1218-22 PMID: 2304237
  35. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis.
    Science. 1990 Mar 16;247(4948):1335-9 PMID: 2107574
  36. Enterically-transmitted non-A, non-B hepatitis.
    Br Med Bull. 1990 Apr;46(2):442-61 PMID: 2116213
  37. Vaccine-induced escape mutant of hepatitis B virus.
    Lancet. 1990 Aug 11;336(8711):325-9 PMID: 1697396
  38. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.
    JAMA. 1990 Nov 7;264(17):2231-5 PMID: 2170702
  39. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3392-6 PMID: 1849654
  40. The role of the hepatitis delta virus in acute hepatitis and in chronic liver disease in Greece.
    Prog Clin Biol Res. 1991;364:51-62 PMID: 2020721
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1994-03-29
Pages
2401-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC43379
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com